Metastatic breast cancers positive for HER2 receptor expression can be effectively imaged with PET using Cu-64 DOTA-trastuzumab, traditionally used as a therapeutic drug, according to a study published online Sept. 12 in the Journal of Nuclear Medicine . {read more}